In a Nutshell: Parkin,
a ubiquitin ligase involved in protein destruction, can be turned off by S-nitrosylation, oxidative stress and
dopamine conjugation, and previous research suggests that parkin ...
ReMynd, a Belgian biotech company, announced today that it has
received follow-on funding from pharma giant Roche for a potentially
disease-modifying Parkinson's drug whose development MJFF ...